Form 8-K - Current report:
SEC Accession No. 0001193125-21-323042
Filing Date
2021-11-08
Accepted
2021-11-08 16:13:05
Documents
15
Period of Report
2021-11-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d156115d8k.htm   iXBRL 8-K 29275
2 EX-10.1 d156115dex101.htm EX-10.1 72070
3 EX-99.1 d156115dex991.htm EX-99.1 5562
7 GRAPHIC g156115g1106023704729.jpg GRAPHIC 3037
  Complete submission text file 0001193125-21-323042.txt   262653

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hsto-20211105.xsd EX-101.SCH 2900
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20211105_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20211105_pre.xml EX-101.PRE 11413
8 EXTRACTED XBRL INSTANCE DOCUMENT d156115d8k_htm.xml XML 3357
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

EIN.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 211388083
SIC: 2834 Pharmaceutical Preparations